US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 2.8000
- -0.1600-5.41%
Close Nov 21 16:00 ET
4.22MMarket Cap-667P/E (TTM)
2.9400High2.7500Low45.44KVolume2.9400Open2.9600Pre Close129.59KTurnover3.05%Turnover RatioLossP/E (Static)1.51MShares23.800052wk High0.23P/B4.17MFloat Cap2.730052wk Low--Dividend TTM1.49MShs Float4870.8000Historical High--Div YieldTTM6.42%Amplitude2.7300Historical Low2.8510Avg Price1Lot Size
Galmed Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 28.75%17.14M | 5.28%9.82M | -11.04%10.81M | -8.29%12.64M | -8.29%12.64M | -30.71%13.31M | -58.35%9.33M | -57.72%12.15M | -60.40%13.79M | -60.40%13.79M |
| -Cash and cash equivalents | 556.14%9.72M | 82.06%1.84M | -12.50%1.46M | 41.91%2.86M | 41.91%2.86M | -63.51%1.48M | -49.04%1.01M | -55.31%1.67M | -30.10%2.02M | -30.10%2.02M |
| -Short-term investments | -37.32%7.42M | -4.03%7.99M | -10.80%9.35M | -16.89%9.78M | -16.89%9.78M | -21.92%11.83M | -59.25%8.32M | -58.08%10.48M | -63.14%11.77M | -63.14%11.77M |
| Receivables | -44.68%426K | -60.41%135K | -55.28%254K | 5.10%165K | 5.10%165K | -33.10%770K | -44.46%341K | -32.62%568K | 98.73%157K | 98.73%157K |
| -Other receivables | -44.68%426K | -60.41%135K | -55.28%254K | 5.10%165K | 5.10%165K | -33.10%770K | -44.46%341K | -32.62%568K | 98.73%157K | 98.73%157K |
| Prepaid assets | ---- | ---- | ---- | -52.84%315K | -52.84%315K | ---- | ---- | ---- | -36.14%668K | -36.14%668K |
| Restricted cash | 3.48%119K | 2.61%118K | 2.63%117K | 2.63%117K | 2.63%117K | 0.88%115K | 0.88%115K | 0.00%114K | 0.00%114K | 0.00%114K |
| Total current assets | 24.56%17.69M | 2.96%10.08M | -12.87%11.18M | -10.09%13.24M | -10.09%13.24M | -30.67%14.2M | -57.69%9.79M | -56.79%12.83M | -59.16%14.72M | -59.16%14.72M |
| Non current assets | ||||||||||
| Net PPE | --0 | --0 | -73.67%74K | -62.91%125K | -62.91%125K | -55.24%175K | -49.21%226K | -43.46%281K | -38.84%337K | -38.84%337K |
| -Gross PPE | --0 | --0 | -73.67%74K | -13.66%1.14M | -13.66%1.14M | -55.24%175K | -49.21%226K | -43.46%281K | -12.14%1.33M | -12.14%1.33M |
| -Accumulated depreciation | ---- | ---- | ---- | -3.14%-1.02M | -3.14%-1.02M | ---- | ---- | ---- | -3.24%-988K | -3.24%-988K |
| Investments and advances | 0.00%3.27M | 0.00%3.27M | 94.81%3.27M | 117.67%3.27M | 117.67%3.27M | --3.27M | --3.27M | --1.68M | --1.5M | --1.5M |
| Total non current assets | -5.09%3.27M | -6.47%3.27M | 70.62%3.34M | 84.54%3.39M | 84.54%3.39M | 779.80%3.44M | 684.49%3.49M | 293.76%1.96M | 233.39%1.84M | 233.39%1.84M |
| Total assets | 18.78%20.95M | 0.48%13.34M | -1.83%14.52M | 0.41%16.63M | 0.41%16.63M | -15.48%17.64M | -43.68%13.28M | -51.02%14.79M | -54.76%16.56M | -54.76%16.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 20.23%2.51M | -42.93%1.55M | -36.99%1.77M | -26.80%1.88M | -26.80%1.88M | -58.44%2.09M | -0.22%2.72M | -50.40%2.8M | -56.34%2.57M | -56.34%2.57M |
| -accounts payable | -8.96%1.34M | -43.79%1.2M | -38.97%1.38M | -26.60%1.88M | -26.60%1.88M | -68.96%1.47M | 2.44%2.14M | -53.13%2.27M | -47.44%2.56M | -47.44%2.56M |
| -Other payable | 89.95%1.17M | -39.79%351K | -28.60%382K | ---- | ---- | 118.79%617K | -8.91%583K | -34.11%535K | -99.31%7K | -99.31%7K |
| Current accrued expenses | ---- | ---- | ---- | 32.14%259K | 32.14%259K | ---- | ---- | ---- | --196K | --196K |
| Current debt and capital lease obligation | ---- | ---- | ---- | -76.02%41K | -76.02%41K | ---- | ---- | ---- | --171K | --171K |
| -Current capital lease obligation | ---- | ---- | ---- | -76.02%41K | -76.02%41K | ---- | ---- | ---- | --171K | --171K |
| Current liabilities | 20.23%2.51M | -42.93%1.55M | -36.99%1.77M | -11.12%2.75M | -11.12%2.75M | -58.44%2.09M | -0.22%2.72M | -50.40%2.8M | -47.37%3.09M | -47.37%3.09M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K |
| -Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -80.79%44K | -80.79%44K |
| Total liabilities | 20.23%2.51M | -42.93%1.55M | -36.99%1.77M | -12.36%2.75M | -12.36%2.75M | -59.16%2.09M | -4.89%2.72M | -51.96%2.8M | -48.62%3.14M | -48.62%3.14M |
| Shareholders'equity | ||||||||||
| Share capital | 300.60%665K | 275.71%263K | 255.71%249K | 198.57%209K | 198.57%209K | 137.14%166K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K |
| -common stock | 300.60%665K | 275.71%263K | 255.71%249K | 198.57%209K | 198.57%209K | 137.14%166K | 0.00%70K | 0.00%70K | 0.00%70K | 0.00%70K |
| Retained earnings | -3.31%-197.26M | -3.11%-195.35M | -3.38%-194.23M | -3.72%-192.95M | -3.72%-192.95M | -4.11%-190.94M | -6.41%-189.46M | -7.77%-187.87M | -10.62%-186.04M | -10.62%-186.04M |
| Paid-in capital | 4.08%215.37M | 3.34%207.31M | 3.37%207.19M | 3.47%207.08M | 3.47%207.08M | 3.48%206.92M | 0.47%200.61M | 0.61%200.44M | 0.69%200.14M | 0.69%200.14M |
| Gains losses not affecting retained earnings | 43.66%-342K | 34.29%-435K | 29.46%-455K | 39.06%-454K | 39.06%-454K | 30.71%-607K | 32.59%-662K | -4.71%-645K | -335.67%-745K | -335.67%-745K |
| Total stockholders'equity | 18.58%18.44M | 11.68%11.79M | 6.39%12.76M | 3.40%13.88M | 3.40%13.88M | -1.28%15.55M | -49.04%10.55M | -50.79%11.99M | -55.99%13.42M | -55.99%13.42M |
| Total equity | 18.58%18.44M | 11.68%11.79M | 6.39%12.76M | 3.40%13.88M | 3.40%13.88M | -1.28%15.55M | -49.04%10.55M | -50.79%11.99M | -55.99%13.42M | -55.99%13.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data